NASDAQ: UTHR       United Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
166.275   -1.435 (0.86%)  164.615 - 168.89  46,802


Avg Volume (4 weeks):379,227
4 Weeks Range:145.79 - 176.31
4 Weeks Price Volatility (%):
52 Weeks Range:75.58 - 176.31
52 Weeks Price Volatility (%):
Average Price Target: 147.00
Price Target Upside/Downside: -19.275


No recent Headlines for this stock.

Business Background

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2278  4120  250  3248 

Top 10 Active Counters
 AMC 4.579+1.069 
 EXPR 3.62+1.83 
 BB 18.431+4.391 
 NOK 4.806+0.606 
 LK 1.38+1.38 
 SNDL 0.599-0.046 
 PLTR 35.01+2.43 
 CTRM 0.384-0.021 
 WPX 9.43+0.48 
 NAKD 0.424-0.018